{"product_id":"deprescribing-and-polypharmacy-in-an-aging-population-9780323991384","title":"Deprescribing and Polypharmacy in an Aging Population","description":"\u003cp\u003e\u003c\/p\u003e\u003cblockquote\u003e\n\u003cbr\u003eDeprescribing and Polypharmacy in an Aging Population is a global initiative that aims to reduce polypharmacy-related drug replated problems (DRPs) by developing, implementing, testing, improving, and educating strategies for deprescribing and optimizing patient safety. \u003c\/blockquote\u003e\u003cp\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e: Paperback \/ softback\u003cbr\u003e\u003cstrong\u003eLength\u003c\/strong\u003e: 166 pages\u003cbr\u003e\u003cstrong\u003ePublication date\u003c\/strong\u003e: 01 June 2023\u003cbr\u003e\u003cstrong\u003ePublisher\u003c\/strong\u003e: Elsevier Science \u0026amp; Technology\u003cbr\u003e\u003c\/p\u003e \u003cp\u003e\u003cbr\u003eReducing polypharmacy-related drug replicated problems (DRPs) is a critical concern for healthcare professionals across global healthcare institutions. Deprescribing and Polypharmacy in an Aging Population provides valuable support in this endeavor by collaborating with patients, families, interprofessional healthcare professionals, and educational institutions. The primary goal is to develop, implement, test, improve upon, and educate on strategies for deprescribing and optimizing patient safety.\u003cbr\u003e\u003cbr\u003ePolypharmacy, the practice of using multiple medications simultaneously by an individual, is prevalent in various patient populations, including those without primary physicians, individuals with mental health conditions, individuals with multiple chronic conditions, and the aging population. This phenomenon arises from various factors, such as the increasing complexity of medical conditions, the desire to alleviate symptoms, and the lack of effective communication between healthcare providers.\u003cbr\u003e\u003cbr\u003eThe consequences of polypharmacy can be significant and detrimental to patient health. Polypharmacy can lead to drug interactions, adverse drug reactions, falls, hospitalization, and increased healthcare costs. It can also compromise patient compliance and reduce the effectiveness of treatment, leading to poorer health outcomes.\u003cbr\u003e\u003cbr\u003eRecognizing the challenges posed by polypharmacy, healthcare professionals are increasingly exploring strategies to address this issue. Deprescribing, which involves reducing or discontinuing unnecessary medications, is one such approach. By identifying and addressing medication-related problems, healthcare professionals can improve patient safety, reduce the risk of adverse drug reactions, and enhance the overall quality of care.\u003cbr\u003e\u003cbr\u003eDeprescribing and Polypharmacy in an Aging Population plays a crucial role in facilitating this effort. By working closely with patients, families, interprofessional healthcare professionals, and educational institutions, healthcare professionals can develop comprehensive deprescribing strategies tailored to individual patient needs. This involves conducting medication reviews, assessing medication effectiveness, identifying potential drug-drug interactions, and developing personalized treatment plans.\u003cbr\u003e\u003cbr\u003eIn addition to deprescribing, healthcare professionals can also optimize patient safety by implementing evidence-based medication management practices. This includes promoting medication adherence, educating patients about the risks and benefits of medications, and ensuring that medications are prescribed and dispensed appropriately.\u003cbr\u003e\u003cbr\u003eCollaboration among healthcare professionals, patients, and their families is essential in achieving successful deprescribing and polypharmacy. Open communication, shared decision-making, and patient education are key components of this process. By involving patients and their families in the decision-making process, healthcare professionals can better understand the patient's perspective and address any concerns or fears related to medication discontinuation.\u003cbr\u003e\u003cbr\u003eFurthermore, healthcare institutions can play a significant role in promoting deprescribing and polypharmacy. By implementing policies and procedures that encourage medication review, reducing unnecessary medication orders, and promoting interdisciplinary collaboration, healthcare institutions can create an environment that supports safe and effective medication management.\u003cbr\u003e\u003cbr\u003eIn conclusion, reducing polypharmacy-related drug replicated problems is a critical concern for healthcare professionals across global healthcare institutions. Deprescribing and Polypharmacy in an Aging Population provides valuable support in this endeavor by collaborating with patients, families, interprofessional healthcare professionals, and educational institutions. By developing, implementing, testing, improving upon, and educating on strategies for deprescribing and optimizing patient safety, healthcare professionals can enhance patient outcomes, reduce the risk of adverse drug reactions, and improve the overall quality of care.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eWeight\u003c\/strong\u003e: 450g\u003cbr\u003e\u003cstrong\u003eDimension\u003c\/strong\u003e: 235 x 191 (mm)\u003cbr\u003e\u003cstrong\u003eISBN-13\u003c\/strong\u003e: 9780323991384\u003c\/p\u003e","brand":"AliElbeddini","offers":[{"title":"Paperback \/ softback","offer_id":44531928826106,"sku":"9780323991384","price":120.49,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/4297\/2845\/products\/1693579807760_book.jpg?v=1693662672","url":"https:\/\/shulphink.com\/products\/deprescribing-and-polypharmacy-in-an-aging-population-9780323991384","provider":"Shulph Ink","version":"1.0","type":"link"}